Takeda to sell nonprescription drug unit to Blackstone

Takeda to sell nonprescription drug unit to Blackstone

Photo taken Aug. 24, 2020, in Tokyo shows the global headquarters building of Takeda Pharmaceutical Co. The company said the same day it will sell its over-the-counter medicine unit Takeda Consumer Healthcare Co. for around 242 billion yen ($2.3 billion) to U.S. investment fund Blackstone Group Inc.

  • Product Code
  • ILEA000200205
  • Registered date
  • 2020/8/24 18:51:23
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2020 Kyodo News
  • Media size
  • 2310 × 1593 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 359.32(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos

    Honda, Nissan eye merger

    TOKYO, Japan, Dec. 18 Kyodo - Combined photo taken from a Kyodo News helicopter on Dec. 18, 2024, shows the headquarters of Honda Motor Co. (L) in Tokyo and Nissan Motor Co. in Yokohama, near Tokyo. The two major Japanese automakers are in talks on the possible establishment of a holding company in a bid to form a global alliance to challenge foreign electric vehicle makers, a source familiar with the deal said the same day. (Kyodo)
      Honda, Nissan eye merger

      Honda, Nissan eye merger

      Combined photo taken from a Kyodo News helicopter on Dec. 18, 2024, shows the headquarters of Honda Motor Co. (L) in Tokyo and Nissan Motor Co. in Yokohama, near Tokyo. The two major Japanese automakers are in talks on the possible establishment of a holding company in a bid to form a global alliance to challenge foreign electric vehicle makers, a source familiar with the deal said the same day.
        Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

        Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

        BAYEUX, FRANCE - OCTOBER 13: A view of Doliprane 1000g boxes placed in front of a computer screen displaying the Sanofi logo, in Bayeux, Calvados, France, on October 13, 2024. Sanofi, the world's fifth-largest pharmaceutical company, is divesting a portion of its business by selling its consumer healthcare division, Opella, which includes around a hundred of its consumer health products, to the American investment fund Clayton, Dubilier and Rice (CDandR) for over 15 billion euros. (Photo by Artur Widak/NurPhoto)
          Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

          Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

          BAYEUX, FRANCE - OCTOBER 13: A view of Doliprane 1000g boxes placed in front of a computer screen displaying the Sanofi logo, in Bayeux, Calvados, France, on October 13, 2024. Sanofi, the world's fifth-largest pharmaceutical company, is divesting a portion of its business by selling its consumer healthcare division, Opella, which includes around a hundred of its consumer health products, to the American investment fund Clayton, Dubilier and Rice (CDandR) for over 15 billion euros. (Photo by Artur Widak/NurPhoto)
            Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

            Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

            BAYEUX, FRANCE - OCTOBER 13: A view of Doliprane 1000g boxes placed in front of a computer screen displaying the Sanofi logo, in Bayeux, Calvados, France, on October 13, 2024. Sanofi, the world's fifth-largest pharmaceutical company, is divesting a portion of its business by selling its consumer healthcare division, Opella, which includes around a hundred of its consumer health products, to the American investment fund Clayton, Dubilier and Rice (CDandR) for over 15 billion euros. (Photo by Artur Widak/NurPhoto)
              Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

              Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

              BAYEUX, FRANCE - OCTOBER 13: A view of Doliprane 1000g boxes placed in front of a computer screen displaying the Sanofi logo, in Bayeux, Calvados, France, on October 13, 2024. Sanofi, the world's fifth-largest pharmaceutical company, is divesting a portion of its business by selling its consumer healthcare division, Opella, which includes around a hundred of its consumer health products, to the American investment fund Clayton, Dubilier and Rice (CDandR) for over 15 billion euros. (Photo by Artur Widak/NurPhoto)
                Dollar tumbles to 157 yen level

                Dollar tumbles to 157 yen level

                Financial monitors at a foreign exchange company in Tokyo show the dollar trading in the 157 yen range in early New York trading on July 11, 2024, down sharply from over 161 yen earlier in the day, in reaction to the release of June's U.S. consumer price index.
                  Astrazeneca

                  Astrazeneca

                  SUQIAN, CHINA - NOVEMBER 20, 2023 - Astrazeneca, Suqian, Jiangsu Province, China, 20 November 2023. (Photo by Costfoto/NurPhoto)
                    Astrazeneca

                    Astrazeneca

                    SUQIAN, CHINA - NOVEMBER 20, 2023 - Astrazeneca, Suqian, Jiangsu Province, China, 20 November 2023. (Photo by Costfoto/NurPhoto)
                      Astrazeneca

                      Astrazeneca

                      SUQIAN, CHINA - NOVEMBER 20, 2023 - Astrazeneca, Suqian, Jiangsu Province, China, 20 November 2023. (Photo by Costfoto/NurPhoto)